MimiVax receives fast-track designation for brain cancer therapy

MimiVax LLC, which spun off from Roswell Park Comprehensive Cancer Center, has been developing its SurVaxM therapy for several years for treatment of glioblastoma.

Researchers outline 200 Los Angeles office buildings fit for apartment conversions

2022 Denver-area Coworking Companies

CRG kills big Creve Coeur project

Jennifer Engeling brings data to her DEI work at Edward Jones

Midtown apartment tower sale sets high-water mark for 2023

Why this 40 Under 40 chose to run for state office

JPMorgan Chase Houston commercial banking team anticipates increased demand, growth in 2023

Senseonics earns green light to take longer-lasting diabetes device international

MimiVax receives fast-track designation for brain cancer therapy

Previous Blue Water Biotech names new CEO, CFO as company faces dual Nasdaq delisting notices

Next State warns of 'potentially fraudulent' mailer seeking cannabis license applicants

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Dollar hires community development leader from Citizens

CBRE promotes Benefield

JPMorgan looks to hire; Goldfinch, Theonys fold: The National Observer Jan. 31, 2023

Online Single Dating Web Site

UAB startup aiming to reverse effects of diabetes

‘Are we going to be next?’: St. Louis restaurants, retail shops worry about break-ins

MENU

FirstStar Group

More Stories

Top 150+ 2018: No. 152 Benjamin F. Edwards & Co.

Previous Blue Water Biotech names new CEO, CFO as company faces dual Nasdaq delisting notices

Next State warns of 'potentially fraudulent' mailer seeking cannabis license applicants

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories